↓ Skip to main content

Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
14 Mendeley